Cerity Partners LLC Sells 9,638 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Cerity Partners LLC lowered its holdings in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 10.3% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 84,363 shares of the company's stock after selling 9,638 shares during the quarter. Cerity Partners LLC owned about 0.47% of Addus HomeCare worth $11,223,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ADUS. UMB Bank n.a. lifted its stake in shares of Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company's stock worth $26,000 after purchasing an additional 88 shares during the period. Quest Partners LLC bought a new position in shares of Addus HomeCare in the 2nd quarter worth about $31,000. Innealta Capital LLC acquired a new stake in Addus HomeCare in the 2nd quarter valued at approximately $44,000. Farther Finance Advisors LLC increased its stake in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock valued at $49,000 after acquiring an additional 366 shares during the period. Finally, Sandia Investment Management LP acquired a new position in Addus HomeCare in the second quarter worth approximately $58,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the business's stock in a transaction on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares of the company's stock, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the transaction, the director now owns 3,866 shares in the company, valued at $502,695.98. This represents a 11.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,500 shares of company stock worth $1,668,265. Company insiders own 4.60% of the company's stock.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS traded down $3.12 during midday trading on Wednesday, hitting $121.29. The company's stock had a trading volume of 107,867 shares, compared to its average volume of 131,573. The business's fifty day simple moving average is $127.91 and its two-hundred day simple moving average is $123.51. The firm has a market capitalization of $2.20 billion, a price-to-earnings ratio of 28.47, a price-to-earnings-growth ratio of 2.15 and a beta of 1.04. Addus HomeCare Co. has a 1 year low of $85.43 and a 1 year high of $136.12.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm's revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.03 earnings per share. Analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Oppenheimer increased their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research note on Monday, September 23rd. Macquarie reaffirmed an "outperform" rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. KeyCorp initiated coverage on Addus HomeCare in a report on Friday, October 11th. They set an "overweight" rating and a $150.00 target price on the stock. TD Cowen lifted their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a "buy" rating in a report on Thursday, August 8th. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $131.63.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.